These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11831899)

  • 1. Designing analogues of mini atrial natriuretic peptide based on structural analysis by NMR and restrained molecular dynamics.
    Sugase K; Oyama Y; Kitano K; Iwashita T; Fujiwara T; Akutsu H; Ishiguro M
    J Med Chem; 2002 Feb; 45(4):881-7. PubMed ID: 11831899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restriction of a peptide turn conformation and conformational analysis of guanidino group using arginine-proline fused amino acids: application to mini atrial natriuretic peptide on binding to the receptor.
    Sugase K; Horikawa M; Sugiyama M; Ishiguro M
    J Med Chem; 2004 Jan; 47(2):489-92. PubMed ID: 14711318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships for mini atrial natriuretic peptide by proline-scanning mutagenesis and shortening of peptide backbone.
    Sugase K; Oyama Y; Kitano K; Akutsu H; Ishiguro M
    Bioorg Med Chem Lett; 2002 May; 12(9):1245-7. PubMed ID: 11965363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformation and calcium-binding properties of a bicyclic nonapeptide.
    Oliva R; Falcigno L; D'Auria G; Zanotti G; Paolillo L
    Biopolymers; 2000-2001; 56(1):27-36. PubMed ID: 11582575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive activity of some peptides related to cycloamanide A (CyA A) and to the active fragment of a peptide immunomodulator from ovine colostrum.
    Bolewska-Pedyczak E; Wieczorek Z; Zimecki M; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):297-301. PubMed ID: 8010869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and conformational analysis by 1H NMR and restrained molecular dynamics simulations of the cyclic decapeptide [Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly].
    Buono RA; Kucharczyk N; Neuenschwander M; Kemmink J; Hwang LY; Fauchère JL; Venanzi CA
    J Comput Aided Mol Des; 1996 Jun; 10(3):213-32. PubMed ID: 8808738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides.
    Gurrath M; Müller G; Kessler H; Aumailley M; Timpl R
    Eur J Biochem; 1992 Dec; 210(3):911-21. PubMed ID: 1483474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
    Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
    J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities.
    Ueda S; Oishi S; Wang ZX; Araki T; Tamamura H; Cluzeau J; Ohno H; Kusano S; Nakashima H; Trent JO; Peiper SC; Fujii N
    J Med Chem; 2007 Jan; 50(2):192-8. PubMed ID: 17228861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicyclic peptides as models of calcium binding sites: synthesis and conformation of a homodetic undecapeptide.
    Oliva R; Falcigno L; D'Auria G; Saviano M; Paolillo L; Ansanelli G; Zanotti G
    Biopolymers; 2000 Jun; 53(7):581-95. PubMed ID: 10766953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of new cyclic disulfide decapeptides that inhibit the binding of AP-1 to DNA.
    Tsuchida K; Chaki H; Takakura T; Yokotani J; Aikawa Y; Shiozawa S; Gouda H; Hirono S
    J Med Chem; 2004 Aug; 47(17):4239-46. PubMed ID: 15293995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function studies of analogues of parathyroid hormone (PTH)-1-34 containing beta-amino acid residues in positions 11-13.
    Peggion E; Mammi S; Schievano E; Silvestri L; Schiebler L; Bisello A; Rosenblatt M; Chorev M
    Biochemistry; 2002 Jun; 41(25):8162-75. PubMed ID: 12069609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: importance of the Ala81 carboxyl group and of a cyclic conformation for induction of experimental allergic encephalomyelitis.
    Tselios T; Probert L; Daliani I; Matsoukas E; Troganis A; Gerothanassis IP; Mavromoustakos T; Moore GJ; Matsoukas JM
    J Med Chem; 1999 Apr; 42(7):1170-7. PubMed ID: 10197961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformation of a cyclic opioid peptide analog by NMR and molecular dynamics simulation.
    Chuang LC; Chen ST; Ya C
    Biochim Biophys Acta; 1993 Nov; 1158(3):209-16. PubMed ID: 8251519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution conformation of an atrial natriuretic peptide variant selective for the type A receptor.
    Fairbrother WJ; McDowell RS; Cunningham BC
    Biochemistry; 1994 Aug; 33(30):8897-904. PubMed ID: 8043577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational behaviour of a cyclolinopeptide A analogue: two-dimensional NMR study of cyclo(Pro1-Pro-Phe-Phe-Ac6c-Ile-ala-Val8).
    Mazzeo M; Isernia C; Rossi F; Saviano M; Pedone C; Paolillo L; Benedetti E; Pavone V
    J Pept Sci; 1995; 1(5):330-40. PubMed ID: 9223012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds.
    Tamamura H; Araki T; Ueda S; Wang Z; Oishi S; Esaka A; Trent JO; Nakashima H; Yamamoto N; Peiper SC; Otaka A; Fujii N
    J Med Chem; 2005 May; 48(9):3280-9. PubMed ID: 15857134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulfide bridge.
    Grieco P; Carotenuto A; Campiglia P; Zampelli E; Patacchini R; Maggi CA; Novellino E; Rovero P
    J Med Chem; 2002 Sep; 45(20):4391-4. PubMed ID: 12238917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.